Abbott Laboratories reported a decline in Q2 profit to $928 million while sales grew on diagnostics strength and the company raised its full-year adjusted EPS guidance.
WSJ07/16, 07:08 PM
- $928 million
- 53 cents a share
- $1.78 billion
- $1.01 a share
Figures as quoted by WSJ
Related assets
Coming up for ABT
Explore next
Latest ABT news
Bloomberg08/21, 04:57 PM
FirstSquawk08/21, 06:28 AM
FirstSquawk08/21, 06:28 AM